Home » Topics » Regulatory

Regulatory
RSS

Treatment of autoimmune diseases with Rituxan

Dec. 20, 2000

CPMP recommends approval of Visudyne therapy for treatment of pathological myopia

Dec. 19, 2000

Schering-Plough seeks additional FDA approval for Rebetol capsules

Dec. 18, 2000

FDA approves pediatric indication for Tamiflu

Dec. 18, 2000

FDA clears new dose of Concerta for ADHD

Dec. 18, 2000

ODAC unanimously recommends approval of Femara as first-line breast cancer treatment

Dec. 15, 2000

New Claritin formulation receives FDA marketing approval

Dec. 14, 2000

FDA approves second indication for Antizol

Dec. 13, 2000

Galenic formulations of antithrombotic agents for s.c. administration

Dec. 12, 2000

FDA approves new indications for Prevacid

Dec. 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...